Pravin Prashant
Astec LifeSciences plan Capex of Rs. 300 - 350 Cr
By Pravin Prashant - November 08, 2022
R&D center would be doing a lot of new product generation projects, process optimization, scale-up and product life cycle management work, full synthetic labs, the kilo labs, the process safety labs, and the population lab
Jubilant Ingrevia to invest Rs. 2,050 crore during FY 22-25
By Pravin Prashant - November 01, 2022
Most of the new growth Capex investments are happening on the Specialty Chemicals and Nutrition side
